Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

9
(from Reference Citation Analysis)

Article PDFs (2)

Cited by > 0 (8)

Searched Name

Alena Markmann

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Ciccone E, Zhu D, Hawke S, Ajeen R, Gunderson A, Lodge E, Shook-Sa BE, Abernathy H, Garrett H, King E, Markmann A, Premkumar L, Juliano JJ, Boyce RM, Aiello A. 1899. The magnitude and durability of the antibody response to mRNA-based vaccination among SARS-CoV-2 seronegative and seropositive healthcare personnel. Open Forum Infect Dis 2022. [PMCID: PMC9752451 DOI: 10.1093/ofid/ofac492.1526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open

Abstract

Background

Development of robust vaccination guidelines against SARS-CoV-2 requires an understanding of the longitudinal antibody (Ab) response to vaccination and interactions with natural infection. Here, we leveraged an observational cohort study of healthcare personnel (HCP) to study the impact of prior SARS-CoV-2 infection on Ab binding and neutralization after mRNA-based vaccination over a 13 month period.

Methods

From July 2020 to February 2022, HCP at an academic medical center provided blood samples biweekly for 12 weeks and monthly thereafter. First and second vaccine doses became available in mid-December 2021 and boosters were available starting in October 2021. Individuals were excluded if they did not provide any samples, if baseline serostatus was unknown, and if they received a monoclonal Ab treatment for COVID. ELISA measured total immunoglobulin (Ig) and IgG binding to SARS-CoV-2 RBD. Neutralization was measured by live virus Nanoluc SARS-CoV-2ic assay.

Demographics, serostatus, and vaccinations for the total study population and the sub-sample of participants with pre- and post-vaccination antibody measurements.

Results

Of 213 participants, 192 met inclusion criteria. A majority had detectable IgG levels 8 months after a second dose. Prior to vaccination, median total Ig was higher among seropositive vs. seronegative participants (3.7 vs 1.0, p< 0.001). After a first dose, the median total Ig response was two-fold higher in seropositive compared to seronegative participants (13.8 vs. 7.0, p=0.009). A similar pattern was noted with IgG binding and neutralization. After the second dose, median IgG increased to similar levels in both seropositive and seronegative participants (22.1 vs. 21.2, p=0.8). Neutralization after the second dose was slightly higher in seropositive vs. seronegative participants (log10 3.1 vs. 2.5, p=0.075).

Durability of IgG responses after second dose of mRNA-based vaccination against SARS-CoV-2

IgG P/N measurements after 5 days post-V2 for the entire study cohort (incident seropositive: yellow circles, prevalent seropositive (red circles), seronegative (open circles) are shown. The solid lines represent Loess curves for incident and prevalent seropositive participants combined (orange line) and those who were seronegative (grey line).

SARS-CoV-2-specific total Ig and IgG subtype responses among healthcare personnel before and after vaccination against SARS-CoV-2 with an mRNA-based vaccine.

Total Ig P/N ratios at pre-vaccine, post-V1, post-vaccine 2 (post-V2), and post-booster dose (post-boost) timepoints by serostatus (seronegative: n(-), seropositive: n(+)) are shown in the left panel. For the pre-vaccine time point, the most recent antibody level prior to vaccination (for those who were vaccinated) or most recent antibody level overall (for those who were not vaccinated) is shown. For the post-vaccine time points, the first measurement after 5 days post-vaccination is included. Individuals who were infected with SARS-CoV-2 at any time after the first vaccine dose are shown as open circles with black outlines. The black numbers next to the circles indicate the number of days between vaccination and sample collection for seropositive individuals. SARS-CoV-2 specific IgG P/N ratios respectively at pre-vaccine, post-V1, post-V2, and post-boost timepoints by serostatus (seronegative: n(-), seropositive: n(+)) are shown in the right panel. One individual tested positive for SARS-CoV-2 by PCR shortly after the second vaccine dose (V2); post-V2 results were excluded for this participant. For the pre-vaccine time point, the most recent antibody level prior to vaccination (for those who were vaccinated) or most recent antibody level overall (for those who were not vaccinated) is shown. For the post-vaccine time points, the first measurement after 5 days post-vaccination is included. The dotted line is a P/N ratio of 2.4, the cut-off associated with 99.3% specificity (SARS-CoV-2 IgG-positive above the line, IgG-negative below). Individuals who were infected with SARS-CoV-2 at any time after the first vaccine dose are shown as open circles with black outlines. The black numbers next to the circles indicate the number of days between vaccination and sample collection for seropositive individuals.

SARS-CoV-2 D614G live virus neutralization among healthcare personnel by serostatus prior to vaccination.

Example neutralization curves are shown in Panel A.

Panel B shows the SARS-CoV-2 D614G live virus neutralization titers displayed as EC50 for seropositive (prevalent and incident) individuals and a subset of seronegative individuals. Samples for seronegative individuals were selected by matching on age and time between vaccination and sample collection to the samples from seropositive individuals.

Conclusion

Antibody responses after SARS-CoV-2 vaccination persist up to 1 year with wide individual variability. Though prior infection was associated with greater Ab responses after a first dose, it did not significantly modify responses after second and third doses. Still, we observed overall slightly higher Ab levels among individuals that had a prior infection before any one of the 3 doses of vaccine. These results suggest that immunity against SARS-CoV-2 prior to vaccination has a role in initial response but does not significantly modify circulating Ab titers after multiple doses of vaccination.

Disclosures

All Authors: No reported disclosures.

Collapse

Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH, Kato T, Lee RE, Yount BL, Mascenik TM, Chen G, Olivier KN, Ghio A, Tse LV, Leist SR, Gralinski LE, Schäfer A, Dang H, Gilmore R, Nakano S, Sun L, Fulcher ML, Livraghi-Butrico A, Nicely NI, Cameron M, Cameron C, Kelvin DJ, de Silva A, Margolis DM, Markmann A, Bartelt L, Zumwalt R, Martinez FJ, Salvatore SP, Borczuk A, Tata PR, Sontake V, Kimple A, Jaspers I, O'Neal WK, Randell SH, Boucher RC, Baric RS. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell 2020;182:429-446.e14. [PMID: 32526206 DOI: 10.1016/j.cell.2020.05] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Revised: 05/11/2020] [Accepted: 05/20/2020] [Indexed: 05/26/2023]

Affiliation(s)

Yixuan J Hou Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Kenichi Okuda Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Caitlin E Edwards Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
David R Martinez Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Takanori Asakura Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Kenneth H Dinnon Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Takafumi Kato Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Rhianna E Lee Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Boyd L Yount Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Teresa M Mascenik Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Gang Chen Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Kenneth N Olivier Laboratory of Chronic Airway Infection, Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
Andrew Ghio National Health and Environmental Effects Research Laboratory, Environmental Protection Agency, Chapel Hill, NC, USA
Longping V Tse Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Sarah R Leist Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Lisa E Gralinski Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Alexandra Schäfer Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Hong Dang Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Rodney Gilmore Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Satoko Nakano Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Ling Sun Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
M Leslie Fulcher Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Alessandra Livraghi-Butrico Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Nathan I Nicely Protein Expression and Purification Core, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Mark Cameron Department of Population and Quantitative Health Science, Case Western Reserve University, Cleveland, OH, USA
Cheryl Cameron Department of Nutrition, Case Western Reserve University, Cleveland, OH, USA
David J Kelvin Department of Microbiology and Immunology, Canadian Center for Vaccinology, Dalhousie University, Halifax, NS, Canada; Laboratory of Immunology, Shantou University Medical College, Shantou, Guangdong, China
Aravinda de Silva Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
David M Margolis Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Alena Markmann Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Luther Bartelt Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Ross Zumwalt Department of Pathology, University of New Mexico, Albuquerque, NM, USA
Fernando J Martinez Division of Pulmonary and Critical Care Medicine, Joan & Sanford I. Weill Medical College of Cornell University, New York, NY, USA
Steven P Salvatore Department of Pathology, Joan & Sanford I. Weill Medical College of Cornell University, New York, NY, USA
Alain Borczuk Department of Pathology, Joan & Sanford I. Weill Medical College of Cornell University, New York, NY, USA
Purushothama R Tata Department of Cell Biology, Regeneration Next Initiative, Duke University Medical Center, Durham, NC, USA
Vishwaraj Sontake Department of Cell Biology, Regeneration Next Initiative, Duke University Medical Center, Durham, NC, USA
Adam Kimple Department of Otolaryngology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Ilona Jaspers Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Wanda K O'Neal Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Scott H Randell Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Richard C Boucher Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Ralph S Baric Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Collapse

Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH, Kato T, Lee RE, Yount BL, Mascenik TM, Chen G, Olivier KN, Ghio A, Tse LV, Leist SR, Gralinski LE, Schäfer A, Dang H, Gilmore R, Nakano S, Sun L, Fulcher ML, Livraghi-Butrico A, Nicely NI, Cameron M, Cameron C, Kelvin DJ, de Silva A, Margolis DM, Markmann A, Bartelt L, Zumwalt R, Martinez FJ, Salvatore SP, Borczuk A, Tata PR, Sontake V, Kimple A, Jaspers I, O'Neal WK, Randell SH, Boucher RC, Baric RS. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell 2020;182:429-446.e14. [PMID: 32526206 PMCID: PMC7250779 DOI: 10.1016/j.cell.2020.05.042] [Citation(s) in RCA: 1039] [Impact Index Per Article: 259.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Revised: 05/11/2020] [Accepted: 05/20/2020] [Indexed: 02/06/2023]

Affiliation(s)

Yixuan J Hou Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Kenichi Okuda Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Caitlin E Edwards Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
David R Martinez Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Takanori Asakura Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Kenneth H Dinnon Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Takafumi Kato Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Rhianna E Lee Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Boyd L Yount Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Teresa M Mascenik Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Gang Chen Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Kenneth N Olivier Laboratory of Chronic Airway Infection, Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
Andrew Ghio National Health and Environmental Effects Research Laboratory, Environmental Protection Agency, Chapel Hill, NC, USA
Longping V Tse Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Sarah R Leist Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Lisa E Gralinski Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Alexandra Schäfer Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Hong Dang Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Rodney Gilmore Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Satoko Nakano Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Ling Sun Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
M Leslie Fulcher Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Alessandra Livraghi-Butrico Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Nathan I Nicely Protein Expression and Purification Core, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Mark Cameron Department of Population and Quantitative Health Science, Case Western Reserve University, Cleveland, OH, USA
Cheryl Cameron Department of Nutrition, Case Western Reserve University, Cleveland, OH, USA
David J Kelvin Department of Microbiology and Immunology, Canadian Center for Vaccinology, Dalhousie University, Halifax, NS, Canada; Laboratory of Immunology, Shantou University Medical College, Shantou, Guangdong, China
Aravinda de Silva Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
David M Margolis Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Alena Markmann Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Luther Bartelt Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Ross Zumwalt Department of Pathology, University of New Mexico, Albuquerque, NM, USA
Fernando J Martinez Division of Pulmonary and Critical Care Medicine, Joan & Sanford I. Weill Medical College of Cornell University, New York, NY, USA
Steven P Salvatore Department of Pathology, Joan & Sanford I. Weill Medical College of Cornell University, New York, NY, USA
Alain Borczuk Department of Pathology, Joan & Sanford I. Weill Medical College of Cornell University, New York, NY, USA
Purushothama R Tata Department of Cell Biology, Regeneration Next Initiative, Duke University Medical Center, Durham, NC, USA
Vishwaraj Sontake Department of Cell Biology, Regeneration Next Initiative, Duke University Medical Center, Durham, NC, USA
Adam Kimple Department of Otolaryngology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Ilona Jaspers Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Wanda K O'Neal Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Scott H Randell Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Richard C Boucher Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Ralph S Baric Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Collapse

Premkumar L, Segovia-Chumbez B, Jadi R, Martinez DR, Raut R, Markmann A, Cornaby C, Bartelt L, Weiss S, Park Y, Edwards CE, Weimer E, Scherer EM, Rouphael N, Edupuganti S, Weiskopf D, Tse LV, Hou YJ, Margolis D, Sette A, Collins MH, Schmitz J, Baric RS, de Silva AM. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Sci Immunol 2020;5:5/48/eabc8413. [PMID: 32527802 PMCID: PMC7292505 DOI: 10.1126/sciimmunol.abc8413] [Citation(s) in RCA: 636] [Impact Index Per Article: 159.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2020] [Accepted: 06/09/2020] [Indexed: 12/19/2022]

Affiliation(s)

Lakshmanane Premkumar Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Bruno Segovia-Chumbez Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Ramesh Jadi Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
David R Martinez Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Rajendra Raut Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Alena Markmann Departments of Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Caleb Cornaby Immunology/Histocompatibility and Immunogenetics Laboratories, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Luther Bartelt Departments of Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Susan Weiss Departments of Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Yara Park Departments of Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Caitlin E Edwards Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Eric Weimer Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Erin M Scherer Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Decatur, Georgia, USA
Nadine Rouphael Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Decatur, Georgia, USA
Srilatha Edupuganti Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Decatur, Georgia, USA
Daniela Weiskopf Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA
Longping V Tse Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Yixuan J Hou Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
David Margolis Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA.,Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.,Departments of Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Alessandro Sette Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.,Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA
Matthew H Collins Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Decatur, Georgia, USA
John Schmitz Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Ralph S Baric Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA.,Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Aravinda M de Silva Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA

Collapse

Premkumar L, Segovia-Chumbez B, Jadi R, Martinez DR, Raut R, Markmann A, Cornaby C, Bartelt L, Weiss S, Park Y, Edwards CE, Weimer E, Scherer EM, Roupael N, Edupuganti S, Weiskopf D, Tse LV, Hou YJ, Margolis D, Sette A, Collins MH, Schmitz J, Baric RS, de Silva AM. The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies. medRxiv 2020. [PMID: 32511572 DOI: 10.1101/2020.05.06.20093377] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]

Becker JC, Hertel M, Markmann A, Shahin M, Werner S, Domschke W, Pohle T. Dynamics and localization of activin A expression in rat gastric ulcers. Scand J Gastroenterol 2003;38:260-7. [PMID: 12737440 DOI: 10.1080/00365520310000636a] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]

Pohle T, Becker JC, Markmann A, Lügering N, Pauels HG, Konturek JW, Domschke W. Aspirin effects on gastric epithelial cell proliferation and cytokine expression. Microsc Res Tech 2001;53:354-9. [PMID: 11376496 DOI: 10.1002/jemt.1103] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]

Pohle T, Brzozowski T, Becker JC, Van der Voort IR, Markmann A, Konturek SJ, Moniczewski A, Domschke W, Konturek JW. Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C. Aliment Pharmacol Ther 2001;15:677-87. [PMID: 11328262 DOI: 10.1046/j.1365-2036.2001.00975.x] [Citation(s) in RCA: 80] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]

Markmann A, Hausser H, Schönherr E, Kresse H. Influence of decorin expression on transforming growth factor-beta-mediated collagen gel retraction and biglycan induction. Matrix Biol 2000;19:631-6. [PMID: 11102752 DOI: 10.1016/s0945-053x(00)00097-4] [Citation(s) in RCA: 64] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]